Spotlight On... Contractor ABL buys Transgene's manufacturing site; Patheon hires an Amgen vet to head up biologics; and much more...

Contract drug developer ABL acquired a French production facility from biotech Transgene, buying its way into Europe with a plant that specializes in treatments using viral vectors. More

> IT firm Aurotech launched software it said can help CROs and drugmakers manage the development process. Item

> Patheon recruited an Amgen ($AMGN) veteran to lead its biologics business. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.